Wegovy cuts BMI in children ages 6 to under 12 in trial
Novo Nordisk reported lower BMI after 68 weeks of Wegovy treatment, while saying longer-term effects in children remain unknown.
Stocks
Markets, companies and the economy, from New York and Frankfurt to Istanbul and Tokyo.
Page 5 of 89
Novo Nordisk reported lower BMI after 68 weeks of Wegovy treatment, while saying longer-term effects in children remain unknown.
Stocks
The multi-year award covers rocket motors and safety devices needed for Lockheed Martin’s production of PAC-3 MSE interceptors.
Stocks
The gift includes 9.225 million Class B shares, as Buffett says his confidence in Berkshire’s new leadership remains strong.
Stocks3 sources
The all-cash deal is expected to close in December, pending a successful tender offer and other closing conditions.
Stocks
The planned Grünheide project includes a new production building, with construction targeted for 2027 and production for 2029.
Stocks2 sources
The roughly $5 billion deal covers 13 facilities that AWS will lease back under a long-term agreement.
Stocks2 sources
CG Oncology reported a 68% lower recurrence risk in a Phase 3 trial and outlined plans for two bladder-cancer submissions.
Stocks
Tyson Foods made its fourth-quarter and fiscal-year results available online and scheduled a conference call for 9 a.m. Eastern.
Stocks
The company forecasts NGTL demand reaching 18 Bcf/d by 2031 and is considering a new pipeline to serve Alberta growth.
Stocks
The logistics company is targeting above 7% organic revenue growth per year through 2030 and issued preliminary financial goals for 2027.
Stocks
The proposed Midland Basin deal includes 176,000 net acres and is expected to close on December 21, subject to customary conditions.
Stocks
The competition authority will examine alleged pricing, customer and territory restrictions involving Siemens software distributor Boğaziçi Yazılım and seven dealers.
Stocks3 sources
The combined utility says it serves 2.2 million electric and natural gas customers across eight states, with shares trading as HZN.
Stocks
The European Commission found no competition concerns, while UniCredit awaits a Polish approval to complete its regulatory process.
Stocks4 sources
Coop Alleanza 3.0 will transfer its 40.92% IGD stake to Carmila, which plans a later offer aimed at delisting IGD.
Stocks
The shares fell after quarterly results showed a wider loss, while brokerages warned that margin pressure may continue.
Stocks
A review of 33 firms found lower targets for Nvidia, while most analysts kept positive ratings ahead of its earnings report.
Stocks2 sources
The Turkish bank aims to provide 1.5 trillion lira in sustainable financing by 2030, it announced at COP31 in Antalya.
Stocks2 sources
The deal would add liquefaction technology to Nextchem’s offering, with licensing EBITDA of at least $25 million expected in 2027.
Stocks
The Phase 2 study missed its primary and secondary endpoints, while Aclaris said the drug was generally well tolerated.
Stocks
The insurer is restructuring as bulk annuity volumes rise, while its shares traded lower on Monday morning.
Stocks
Coal India will sell a 10% stake in its subsidiary, with the offer scheduled to open November 19 and close November 23.
Stocks
The package includes about €160 million in firm orders and €210 million in options, with deliveries expected to start this year.
Stocks
The approval makes Gazyva the first FDA-approved treatment for the kidney disease, based on a phase III trial against tacrolimus.
Stocks